Lack of Pharmacokinetic Drug Interaction Between Oral Posaconazole and Caspofungin or Micafungin

Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination

(2009) Susanne Perkhofer et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Antifungal Therapy for Invasive Fungal Diseases in Allogeneic Stem Cell Transplant Recipients: An Update

(2009) Dustin T. Wilson et al.   MYCOPATHOLOGIA

A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients

(2008) Christina T. Rieger et al.   ANNALS OF HEMATOLOGY

Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers

(2008) G. Krishna et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Combination Polyene‐Caspofungin Treatment of Rhino‐Orbital‐Cerebral Mucormycosis

(2008) Caitlin Reed et al.   CLINICAL INFECTIOUS DISEASES

Micafungin

(2008) Sarah A Cross et al.   DRUGS

Successfully treatedCandida kruseiinfection of the lumbar spine with combined caspofungin/posaconazole therapy

(2008) A. Schilling et al.   MEDICAL MYCOLOGY

Antifungal agents – clinical pharmacokinetics and drug interactions

(2008) Hans-Peter Lipp   MYCOSES